Center-Authored Papers

Filters: Author is True, Lawrence D  [Clear All Filters]
2008
Pascal LE, True LD, Campbell DS, Deutsch EW, Risk M, Coleman IM, Eichner LJ, Nelson PS, Liu AY.  2008.  Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate.. BMC genomics. 9:246. Abstract
Morrissey C, True LD, Roudier MP, Coleman IM, Hawley S, Nelson PS, Coleman R, Wang Y-C, Corey E, Lange PH et al..  2008.  Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases.. Clinical & experimental metastasis. 25(4):377-88. Abstract
Klezovitch O, Risk M, Coleman I, Lucas JM, Null M, True LD, Nelson PS, Vasioukhin VI.  2008.  A causal role for ERG in neoplastic transformation of prostate epithelium.. Proceedings of the National Academy of Sciences of the United States of America. 105(6):2105-10. Abstract
Holcomb IN, Grove DI, Kinnunen M, Friedman CL, Gallaher IS, Morgan TM, Sather CL, Delrow JJ, Nelson PS, Lange PH et al..  2008.  Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients.. Cancer research. 68(14):5599-608. Abstract
Montgomery BR, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, Higano CS, True LD, Nelson PS.  2008.  Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.. Cancer research. 68(11):4447-54. Abstract
Lin B, Utleg AG, Gravdal K, White JT, Halvorsen OJ, Lu W, True LD, Vessella R, Lange PH, Nelson PS et al..  2008.  WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrence.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(5):1397-406. Abstract
Sim HG, Telesca D, Culp SH, Ellis WJ, Lange PH, True LD, Lin DW.  2008.  Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence.. The Journal of urology. 179(5):1775-9. Abstract
2009
Qian DZ, Huang C-Y, O'Brien CA, Coleman IM, Garzotto M, True LD, Higano CS, Vessella R, Lange PH, Nelson PS et al..  2009.  Prostate cancer-associated gene expression alterations determined from needle biopsies.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(9):3135-42. Abstract
Holcomb IN, Young JM, Coleman IM, Salari K, Grove DI, Hsu L, True LD, Roudier MP, Morrissey CM, Higano CS et al..  2009.  Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer.. Cancer research. 69(19):7793-802. Abstract
2010
Mostaghel EA, Geng L, Holcomb I, Coleman IM, Lucas J, True LD, Nelson PS.  2010.  Variability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: implications for prostate cancer chemoprevention.. Cancer research. 70(4):1286-95. Abstract
Wright JL, Dalkin BL, True LD, Ellis WJ, Stanford JL, Lange PH, Lin DW.  2010.  Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality.. The Journal of urology. 183(6):2213-8. Abstract
Morrissey C, Lai JS, Brown LG, Wang Y-C, Roudier MP, Coleman IM, Gulati R, Vakar-Lopez F, True LD, Corey E et al..  2010.  The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells.. The Prostate. 70(4):412-24. Abstract
Risk MC, Knudsen BS, Coleman I, Dumpit RF, Kristal AR, Lemeur N, Gentleman RC, True LD, Nelson PS, Lin DW.  2010.  Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect.. Clinical cancer research : an official journal of the American Association for Cancer Research. 16(22):5414-23. Abstract
True LD, Zhang H, Ye M, Huang C-Y, Nelson PS, von Haller PD, Tjoelker LW, Kim J-S, Qian W-J, Smith RD et al..  2010.  CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 23(10):1346-56. Abstract
2011
Zhang X, Morrissey C, Sun S, Ketchandji M, Nelson PS, True LD, Vakar-Lopez F, Vessella RL, Plymate SR.  2011.  Androgen receptor variants occur frequently in castration resistant prostate cancer metastases.. PloS one. 6(11):e27970. Abstract
2013
Lee F, Gottsch H, Ellis WJ, True LD, Lin DW, Wright JL.  2013.  Differences in Upgrading of Prostate Cancer in Prostatectomies between Community and Academic Practices.. Advances in urology. 2013:471234. Abstract
Akfirat C, Zhang X, Ventura A, Berel D, Colangelo ME, Miranti CK, Krajewska M, Reed JC, Higano CS, True LD et al..  2013.  Tumor Cell Survival Mechanisms in Lethal Metastatic Prostate Cancer Differ Between Bone and Soft Tissue Metastases.. The Journal of pathology. Abstract
Hawley S, Fazli L, McKenney JK, Simko J, Troyer D, Nicolas M, Newcomb LF, Cowan JE, Crouch L, Ferrari M et al..  2013.  A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray.. Advances in anatomic pathology. 20(1):39-44. Abstract
Larson SR, Zhang X, Dumpit R, Coleman I, Lakely B, Roudier M, Higano CS, True LD, Lange PH, Montgomery B et al..  2013.  Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases.. The Prostate. 73(9):932-40. Abstract
Ho ME, Quek S-I, True LD, Morrissey C, Corey E, Vessella RL, Dumpit R, Nelson PS, Maresh EL, Mah V et al..  2013.  Prostate cancer cell phenotypes based on AGR2 and CD10 expression.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 26(6):849-859. Abstract
2014
Mostaghel EA, Nelson PS, Lange P, Lin DW, Taplin ME, Balk S, Ellis W, Kantoff P, Marck B, Tamae D et al..  2014.  Targeted androgen pathway suppression in localized prostate cancer: a pilot study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(3):229-37. Abstract
Izard JP, True LD, May P, Ellis WJ, Lange PH, Dalkin B, Lin DW, Schmidt RA, Wright JL.  2014.  Prostate Cancer That Is Within 0.1 mm of the Surgical Margin of a Radical Prostatectomy Predicts Greater Likelihood of Recurrence.. The American journal of surgical pathology. 38(3):333-8. Abstract
Mossanen M, Calvert JK, Wright JL, True LD, Lin DW, Gore JL.  2014.  Readability of urologic pathology reports: The need for patient-centered approaches.. Urologic oncology. Abstract
2015
Brooks JD, Wei W, Hawley S, Auman H, Newcomb L, Boyer H, Fazli L, Simko J, Hurtado-Coll A, Troyer DA et al..  2015.  Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients.. PloS one. 10(7):e0132343. Abstract
Haider M, Zhang X, Coleman I, Ericson N, True LD, Lam H-M, Brown LG, Ketchanji M, Nghiem B, Lakely B et al..  2015.  Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases.. Clinical & experimental metastasis. Abstract